Canephron Urinary Tract Support

Proven to reduce antibiotic use.

Canephron relieves active symptoms and helps reduce the occurrence of localised UTIs and medically diagnosed cystitis, and supports urinary tract health and function. 

The anti-inflammatory [4], analgesic [5], anti-spasmodic [6], and bacterial flushing [7] effects relieve all the major symptoms of localised UTIs in a comparable manner to that of antibiotics [8].

Canephron is endorsed and recommended as a first line, antibiotic sparing treatment for UTIs/cystitis in the European Association of Urology Guidelines [10], and this Guideline is endorsed and adopted [11] by the Urology Society of Australia and New Zealand in the treatment of UTIs/cystitis.

One pack contains 30 coated tablets.

Adults and children aged over 12: Take 1 coated tablet, 3 times daily. Do not exceed the recommended dose. Can be used in conjunction with antibiotics.

Each coated tablets contains 36 mg Centaurium erythraea (centaury) herb powder, 36 mg Levisticum officinale (lovage) root powder, 36 mg Rosmarinus officinalis L. (rosemary) leaf powder.

Where To Buy
REFERENCES:
1 Localised (and Systemic) UTIs is the revised classification approach to UTIs developed by the EAU in their recent guideline update (2025) and adopted by
USANZ. It serves to enhance consistency in clinical practice and replaces “uncomplicated” and “complicated”
2 Wagenlehner F. M. et al., Urol Int., 2018, 101(3), 327-336. This clinical trial was sponsored by Bionorica SE, Germany, and coordinated by the contract research organisation Clinipace Worldwide.
3 Anthony WE, Wang B, Sukhum KV, et al. Acute and persistent effects of commonly used antibiotics on the gut microbiome and resistome in healthy adults.
Cell Rep. 2022;39(2):110649.
4 Nausch B. et al., Phytomedicine 2019 (60) 152987, Butler et al., Urol Int 2023;107:778–784
5 Nausch B. et al., Phytomedicine 2019 (60) 152987, Alidjanov J. et al., Investig Clin Urol 2020;61:498-507
6 BrenneisC. et al., Poster 13th International Congress Ethnopharmacology, Graz 2012, Sabadash, Shulyak, Clinical Phytoscience2017 3:9
7 KünstleG. et al., Poster EAU, Mailand2013
8 Wagenlehner F. M. et al., Urol Int., 2018, 101(3), 327-336. This clinical trial was sponsored by Bionorica SE, Germany, and coordinated by the contract research organisation Clinipace Worldwide.
9 Nausch et al., Antibiotics, 2022, 11, 1331
10 EAU Guidelines on Urological infections 2025
11 https://www.usanz.org.au/info-resources/position-statements-guidelines